TipRanks
Go Ultimate55% OFF

Myriad Genetics (0K3W) Share Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

0K3W Analyst Ratings

Hold
8Ratings
1Buy4Hold3Sell
Based on 8 analysts giving stock ratings to Myriad Genetics in the past 3 months

0K3W Stock 12 Month Forecast

$3.83▼(-39.23% Downside)
Based on 8 Wall Street analysts offering 12 month price targets for Myriad Genetics in the last 3 months. The average price target is $3.83 with a high forecast of $8.00 and a low forecast of $2.00. The average price target represents a -39.23% change from the last price of $6.30.
Highest Price Target$8.00Average Price Target$3.83Lowest Price Target$2.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for GB:0K3W
Price TargetFollowArticle
Craig-Hallum$8buy26.98%UpsideReiterated10/21/26
Bank of America Securities$3.20sell-49.21%DownsideReiterated10/20/26
TD Cowen$4→$4.50hold-28.57%DownsideReiterated10/13/26
UBS Analyst forecast on GB:0K3WUnknown AnalystNot RankedUBS$6→$3.60hold-42.86%DownsideInitiated09/08/26
Piper Sandler$8.50→$2sell-68.25%DownsideDowngraded09/01/26
Jefferies Analyst forecast on GB:0K3WUnknown AnalystNot RankedJefferies$2.50sell-60.32%DownsideReiterated08/21/26
Stephens$3hold-52.38%DownsideAssigned08/18/26
Guggenheim Analyst forecast on GB:0K3WUnknown AnalystNot RankedGuggenheim―hold―Reiterated08/03/26
Raymond James$6.53→$8buy26.98%UpsideReiterated01/13/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AORTArtivion
MDWDMediwound
IMUXImmunic
RZLTRezolute
DFTXDefinium Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Myriad Genetics

3 Months
Andrew Cooper
Andrew CooperRaymond James
Success Rate5/8 ratings generated profit
63%
Average Return
-0.92%

Copying Andrew Cooper's trades and holding each position for 3 Months would result in 62.50% of your transactions generating a profit, with an average return of -0.92% per trade.

1 Year
William Bonello
William BonelloCraig-Hallum
Success Rate4/8 ratings generated profit
50%
Average Return
+3.67%

Copying William Bonello's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +3.67% per trade.

2 Years
William Bonello
William BonelloCraig-Hallum
Success Rate6/8 ratings generated profit
75%
Average Return
+22.00%

Copying William Bonello's trades and holding each position for 2 Years would result in 75.00% of your transactions generating a profit, with an average return of +22.00% per trade.

0K3W Analyst Recommendation Trends

05101520Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for 0K3W
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy41111
Buy00011
Hold66863
Sell23442
Strong Sell00000
total121013127

In the current month, 0K3W has received 2 Buy Ratings, 3 Hold Ratings, and 2 Sell Ratings. 0K3W average Analyst price target in the past 3 months is 3.83.

0K3W Financial Forecast

$-2$-1.25$-0.5$0.25$1Q4 2025Q2 2026Q3 2026
High$-0.15
Consensus$-0.20
Low$-0.27

0K3W Earnings Forecast

Next quarter’s earnings estimate for 0K3W is -$0.20 with a range of -$0.27 to -$0.15. The previous quarter’s EPS was -$0.25. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$188.6M$193.9M$199.2M$204.5M$209.8MQ4 2025Q2 2026Q3 2026
High$193M
Consensus$191M
Low$189M

0K3W Sales Forecast

Next quarter’s sales forecast for 0K3W is $191.33M with a range of $188.60M to $192.64M. The previous quarter’s sales results were $190.70M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

0K3W Stock Forecast FAQ

What is GB:0K3W’s average 12-month price target, according to analysts?
Based on analyst ratings, Myriad Genetics’s 12-month average price target is $3.83.
What is GB:0K3W’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for GB:0K3W, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Myriad Genetics a Buy, Sell or Hold?
Myriad Genetics has a consensus rating of Hold, which is based on 1 buy ratings, 4 hold ratings and 3 sell ratings.
What is Myriad Genetics’s share price target?
The average share price target for Myriad Genetics is $3.83. This is based on 8 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is $8.00, and the lowest forecast is $2.00. The average share price target represents a 39.23% decrease from the current price of $6.3.
What do analysts say about Myriad Genetics?
Myriad Genetics’s analyst rating consensus is a Hold. This is based on the ratings of 8 Wall Street analysts.
How can I buy shares of Myriad Genetics?
To buy shares of GB:0K3W, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.